Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers

Journal of Molecular Biology

Volumn 341, Issue 1, 2004, Pages 303-318

  Lamken, Peter ^a   Lata, Suman ^a   Gavutis, Martynas ^a   Piehler, Jacob ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

IFN, human type I interferon; protein protein interaction; reflectometric interference spectroscopy; solid supported lipid bilayer; total internal reflection fluorescence spectroscopy; type I interferon receptor

Indexed keywords

ALPHA2 INTERFERON; INTERFERON RECEPTOR; ISOPROTEIN; LIGAND; LIPID;

ARTICLE; BINDING AFFINITY; FLUORESCENCE SPECTROSCOPY; KINETICS; LIQUID; PRIORITY JOURNAL; SOLID;

EID: 4143062575     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.05.059     Document Type: Article

References (47)

1. Deonarain R., Chan D.C., Platanias L.C., Fish E.N. Interferon-alpha/beta- receptor interactions: a complex story unfolding. Curr. Pharm. Des. 8:2002;2131-2217
2. Uze G., Lutfalla G., Mogensen K.E. Alpha and beta interferons and their receptor and their friends and relations. J. Interferon Cytokine Res. 15:1995;3-26
3. Abramovich C., Shulman L.M., Ratovitski E., Harroch S., Tovey M., Eid P., Revel M. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J. 13:1994;5871-5877
4. Platanias L.C., Uddin S., Domanski P., Colamonici O.R. Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J. Biol. Chem. 271:1996;23630-23633
5. Croze E., Russell-Harde D., Wagner T.C., Pu H., Pfeffer L.M., Perez H.D. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. J. Biol. Chem. 271:1996;33165-33168
6. Mintzer R.J., Croze E., Rubanyi G.M., Johns A. Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells. J. Interferon Cytokine Res. 18:1998;939-945
7. Domanski P., Nadeau O.W., Platanias L.C., Fish E., Kellum M., Pitha P., Colamonici O.R. Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signalling specificity for IFNalpha2 and IFNbeta. J. Biol. Chem. 273:1998;3144-3147
8. Russell-Harde D., Wagner T.C., Perez H.D., Croze E. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 255:1999;539-544
9. Grumbach I.M., Fish E.N., Uddin S., Majchrzak B., Colamonici O.R., Figulla H.R., et al. Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-beta compared with IFN- alpha. J. Interferon Cytokine Res. 19:1999;797-801
10. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA. 95:1998;15623-15628
11. da Silva A.J., Brickelmaier M., Majeau G.R., Lukashin A.V., Peyman J., Whitty A., Hochman P.S. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b versus IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22:2002;173-188
12. Runkel L., Pfeffer L., Lewerenz M., Monneron D., Yang C.H., Murti A., et al. Differences in activity between alpha and beta type I interferons explored by mutational analysis. J. Biol. Chem. 273:1998;8003-8008
13. Piehler J., Schreiber G. Mutational and structural analysis of the binding interface between type I interferons and their receptor ifnar2. J. Mol. Biol. 294:1999;223-237
14. Piehler J., Roisman L.C., Schreiber G. New structural and functional aspects of the type I interferon- receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem. 275:2000;40425-40433
15. Roisman L.C., Piehler J., Trosset J.Y., Scheraga H.A., Schreiber G. Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking. Proc. Natl Acad. Sci. USA. 98:2001;13231-13236
16. Chill J.H., Quadt S.R., Levy R., Schreiber G., Anglister J. The human type I interferon receptor. NMR structure reveals the molecular basis of ligand binding. Structure (Camb). 11:2003;791-802
17. Runkel L., De Dios C., Karpusas M., Baker D., Li Z., Zafari M., et al. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody- based methods and alanine substitution mutagenesis. J. Interferon Cytokine Res. 21:2001;931-941
18. Lu J., Chuntharapai A., Beck J., Bass S., Ow A., De Vos A.M., et al. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2. J. Immunol. 160:1998;1782-1788
19. Goldman L.A., Cutrone E.C., Dang A., Hao X., Lim J.K., Langer J.A. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR- 1 chimeras. Biochemistry. 37:1998;13003-13010
20. Cutrone E.C., Langer J.A. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding. J. Biol. Chem. 276:2001;17140-17148
21. Arduini R.M., Strauch K.L., Runkel L.A., Carlson M.M., Hronowski X., Foley S.F., et al. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains. Protein Sci. 8:1999;1867-1877
22. Wells J.A. Binding in the growth hormone receptor complex. Proc. Natl Acad. Sci. USA. 93:1996;1-6
23. Letzelter F., Wang Y., Sebald W. The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain. Eur. J. Biochem. 257:1998;11-20
24. Ozbek S., Grotzinger J., Krebs B., Fischer M., Wollmer A., Jostock T., et al. The membrane proximal cytokine receptor domain of the human interleukin- 6 receptor is sufficient for ligand binding but not for gp130 association. J. Biol. Chem. 273:1998;21374-21379
25. Livnah O., Stura E.A., Middleton S.A., Johnson D.L., Jolliffe L.K., Wilson I.A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 283:1999;987-990
26. Bernat B., Pal G., Sun M., Kossiakoff A.A. Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc. Natl Acad. Sci. USA. 100:2003;952-957
27. Remy I., Wilson I.A., Michnick S.W. Erythropoietin receptor activation by a ligand-induced conformation change. Science. 283:1999;990-993
28. Grotzinger J. Molecular mechanisms of cytokine receptor activation. Biochim. Biophys. Acta. 1592:2002;215-223
29. Krause C.D., Mei E., Xie J., Jia Y., Bopp M.A., Hochstrasser R.M., Pestka S. Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells. Mol. Cell Proteomics. 1:2002;805-815
30. Lenaz G. Lipid fluidity and membrane protein dynamics. Biosci. Rep. 7:1987;823-837
31. Piehler J., Schreiber G. Fast transient cytokine-receptor interactions monitored in real time by reflectometric interference spectroscopy. Anal. Biochem. 289:2001;173-186
32. Poo H., Krauss J.C., Mayo-Bond L., Todd R.F. 3rd, Petty H.R. Interaction of Fc gamma receptor type IIIB with complement receptor type 3 in fibroblast transfectants: evidence from lateral diffusion and resonance energy transfer studies. J. Mol. Biol. 247:1995;597-603
33. Lim J.K., Xiong J., Carrasco N., Langer J.A. Intrinsic ligand binding properties of the human and bovine alpha- interferon receptors. FEBS Letters. 350:1994;281-286
34. Frank S.J. Receptor dimerization in GH and erythropoietin action-it takes two to tango, but how? Endocrinology. 143:2002;2-10
35. Sebald W., Mueller T.D. The interaction of BMP-7 and ActRII implicates a new mode of receptor assembly. Trends Biochem. Sci. 28:2003;518-521
36. Gent J., Van Den Eijnden M., Van Kerkhof P., Strous G.J. Dimerization and signal transduction of the growth hormone receptor. Mol. Endocrinol. 17:2003;967-975
37. Cunningham B.C., Ultsch M., De Vos A.M., Mulkerrin M.G., Clauser K.R., Wells J.A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 254:1991;821-825
38. Takaoka A., Mitani Y., Suemori H., Sato M., Yokochi T., Noguchi S., et al. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science. 288:2000;2357-2360
39. Pearce K.H. Jr, Cunningham B.C., Fuh G., Teeri T., Wells J.A. Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry. 38:1999;81-89
40. Whitty A., Raskin N., Olson D.L., Borysenko C.W., Ambrose C.M., Benjamin C.D., Burkly L.C. Interaction affinity between cytokine receptor components on the cell surface. Proc. Natl Acad. Sci. USA. 95:1998;13165-13170
41. Piehler J., Schreiber G. Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFN alpha 2. J. Mol. Biol. 289:1999;57-67
42. Schmitt H.M., Brecht A., Piehler J., Gauglitz G. An integrated system for optical biomolecular interaction analysis. Biosens. Bioelectron. 12:1997;809-816
43. Piehler J., Brecht A., Gauglitz G. Affinity detection of low molecular weight analytes. Anal. Chem. 68:1996;139-143
44. Piehler J., Brecht A., Valiokas R., Liedberg B., Gauglitz G. A high-density poly(ethylene glycol) polymer brush for immobilization on glass-type surfaces. Biosens. Bioelectron. 15:2000;473-481
45. Brian A.A., McConnell H.M. Allogeneic stimulation of cytotoxic T cells by supported planar membranes. Proc. Natl Acad. Sci. USA. 81:1984;6159-6163
46. Piehler J., Brecht A., Giersch T., Hock B., Gauglitz G. Assessment of affinity constants by rapid solid phase detection of equilibrium binding in a flow system. J. Immunol. Methods. 201:1997;189-206
47. Axelrod D., Koppel D.E., Schlessinger J., Elson E., Webb W.W. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys. J. 16:1976;1055-1069